Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
LeukemiaLymphomaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

methylprednisolone

PROCEDURE

umbilical cord blood transplantation

RADIATION

radiation therapy

Trial Locations (23)

11030

North Shore University Hospital, Manhasset

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

15213

Children's Hospital of Pittsburgh, Pittsburgh

27710

Duke Comprehensive Cancer Center, Durham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

49503

Spectrum Health and DeVos Children's Hospital, Grand Rapids

55455

University of Minnesota Cancer Center, Minneapolis

63104

Cardinal Glennon Children's Hospital, St Louis

64108

Children's Mercy Hospital, Kansas City

70118

Children's Hospital of New Orleans, New Orleans

75230

Medical City Dallas Hospital, Dallas

92868

Children's Hospital of Orange County, Orange

98109

Fred Hutchinson Cancer Research Center, Seattle

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

90027-0700

Children's Hospital Los Angeles, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

20010-2970

Children's National Medical Center, Washington D.C.

46202-5289

Indiana University Cancer Center, Indianapolis

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

Warren Grant Magnuson Clinical Center, Bethesda

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

07601

Cancer Center at Hackensack University Medical Center, Hackensack

44106-5065

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00003913 - Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | Biotech Hunter | Biotech Hunter